NCT06675240 Meditative Neurofeedback for Depression
| NCT ID | NCT06675240 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Diego |
| Condition | Depression - Major Depressive Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 27 participants |
| Start Date | 2024-11-15 |
| Primary Completion | 2026-11-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 27 participants in total. It began in 2024-11-15 with a primary completion date of 2026-11-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this open-label single-arm study is to test a meditative neurofeedback intervention for depressed mood.
Eligibility Criteria
Inclusion Criteria: * moderate depression per PHQ9 symptom ratings Exclusion Criteria: * active substance abuse/dependence * psychotic disorders * bipolar disorder * displaying acutely suicidal behaviors
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06675240 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Depression - Major Depressive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06675240 currently recruiting?
Yes, NCT06675240 is actively recruiting participants. Contact the research team at braine@ucsd.edu for enrollment information.
Where is the NCT06675240 trial being conducted?
This trial is being conducted at La Jolla, United States.
Who is sponsoring the NCT06675240 clinical trial?
NCT06675240 is sponsored by University of California, San Diego. The trial plans to enroll 27 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.